We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Valutek Donation Supports TGen's Genomic Research and Discovery Programs

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Valutek Donation Supports TGen's Genomic Research and Discovery Programs"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Valutek has made a $10,000 product donation to the Translational Genomics Research Institute (TGen). The contribution actively supports Phoenix's burgeoning biotech movement and directly benefits TGen's research initiatives.

"Valutek has a huge customer base in the biotech industry, and we're thrilled to support an organization that does such noble and exciting work," said Greg Heiland, CEO and President of Valutek.

"TGen is on the cutting edge of translational genomics research, and will continue to buoy the emerging biotechnology movement here in Phoenix. We will, in turn, provide products and services to TGen that will fuel this growth," Heiland continued.

In-kind donations are a valuable resource for TGen. Gifts like the contribution from Valutek help fund TGen's research, which is focused on developing earlier diagnoses and smarter treatments for many human diseases, including cancer, diabetes and neurological disorders.

According to TGen Foundation President Michael Bassoff, "Valutek's contribution is a meaningful donation that directly and immediately benefits our researchers. TGen is delighted to partner with Valutek and we look forward to working with Valutek in our ongoing research efforts."